Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Correction

Correction to: Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients

Authors: Elisabetta Venturelli, Annalisa Orenti, Aline S. C. Fabricio, Giulia Garrone, Roberto Agresti, Biagio Paolini, Chiara Bonini, Massimo Gion, Franco Berrino, Christine Desmedt, Danila Coradini, Elia Biganzoli

Published in: BMC Cancer | Issue 1/2018

Login to get access

Excerpt

Following publication of the original article [1], the authors reported that the affiliation of author Annalisa Orenti was omitted …
Literature
1.
Metadata
Title
Correction to: Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients
Authors
Elisabetta Venturelli
Annalisa Orenti
Aline S. C. Fabricio
Giulia Garrone
Roberto Agresti
Biagio Paolini
Chiara Bonini
Massimo Gion
Franco Berrino
Christine Desmedt
Danila Coradini
Elia Biganzoli
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4799-2

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue

Research article

Incidence and risk factors of subsyndromal delirium after curative resection of gastric cancer

Research article

Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells

Research article

ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells

Case report

Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report

Research article

A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer

Research article

Liver cancer mortality trends in South Africa: 1999–2015
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits